Research

What is the risk of anaphylaxis from the covid-19 vaccine?

Evaluation of anaphylaxis risk by skin testing with Covid-19 messenger RNA vaccines on patients with anaphylaxis

Anapylaxis Risk Analysis via Skin Testing with Covid-19 Vaccines     Vaccination has been found to be effective in reducing the risks of infection of severe acute respiratory syndrome coronavirus and severe coronavirus disease 2019 (COVID-19) outcomes. In the United States, Pfizer-BioNTech and Moderna COVID-19 vaccines (aka the messenger RNA [mRNA] vaccines) have been used …

Evaluation of anaphylaxis risk by skin testing with Covid-19 messenger RNA vaccines on patients with anaphylaxis Read More »

No increased risk for asthma patients for COVID-19

What is my risk of COVID-19 due to Asthma?

No Evidence Suggests Asthma puts patients at higher risk for COVID-19 Covid-19 pandemic frightens a lot of people and traumatically disrupted our social lives.  Since virus SARS-COV-2 (the virus which cause COVID-19 syndrome) may attack the lungs there is obvious concern for patients with chronic respiratory diseases including asthma. Initial information about risk of severe disease …

What is my risk of COVID-19 due to Asthma? Read More »